MedTrace Logo

Modulation of Inflammation by Medium Cut Off Membranes

NCT03270371 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-09-01

No results posted yet for this study

Summary

This study examines whether medium-cut off dialysis results in improved blood purification of large middle molecules e.g. inflammatory molecules compared to hemodialysis (HD) treatments with conventional high-flux dialyzers.

Conditions

Interventions

DEVICE

Medium cut off dialysis

Hemodialysis

DEVICE

Standard High Flux Dialyzer

Hemodialysis

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Christoph Schmaderer, MD · attending Department of Nephrology, Klinikum rechts der Isar

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-10-31
Completion
2019-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03270371 on ClinicalTrials.gov